CrossRef Survival benefits of different immunotherapies for hepatocellular carcinoma: a meta-analysis highlighting age, gender, etiology, and tumor burden Ming-Cheng Guan, Na Li, Qian Ding, Di Sun, Hao Li, Mei Yang, Lei Hong, Hong Zhu Frontiers in Immunology .2025;[Epub] CrossRef Visittovisit variability of inflammationimmunity indices and prognosis in hepatocellular carcinoma Qiajun Du, Youli Zhao, Jing Yang, Yongxin Yang BMC Gastroenterology .2025;[Epub] CrossRef Biomimetic Nanomedicine for SenescenceModulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma Shiji Fang, Liyun Zheng, Bin Lin, Jiale Chen, Dehai Hou, Yiming Ding, Mengzhu Han, Pan Qin, Mengyuan Wang, Xiaoju Guo, Yeyu Zhang, Gaofeng Shu, Fazong Wu, Jianfei Tu, Minjiang Chen, Zhongwei Zhao, Zhuang Liu, Jiansong Ji Advanced Science .2025;[Epub] CrossRef Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma patients with normal serum alpha-fetoprotein levels Kuan-Jung Huang, Chun-Ting Ho, Pei-Chang Lee, San-Chi Chen, Chien-An Liu, Shu-Cheng Chou, I-Cheng Lee, Yi-Hsiang Huang, Jiing-Chyuan Luo, Ming-Chih Hou, Jaw-Ching Wu, Chien-Wei Su Journal of the Chinese Medical Association .2025

The brain is one of the earliest and most consequential targets of estrogen withdrawal
No need to soak the beans or boil them on the stove for hours
Heres the skinny and what you can do to push back against regulatory overreach , bad science , and general misinformation about compounded therapies
How We Evaluated These Programs Before naming the three, here are the four dimensions that mattered